Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
11/19/1997 | EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors |
11/19/1997 | EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
11/19/1997 | EP0807105A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
11/19/1997 | EP0806967A1 Gene transfer for treating a connective tissue of a mammalian host |
11/19/1997 | EP0806960A1 Extracts of shark cartilage, process of production and uses thereof |
11/19/1997 | EP0806946A2 Use of carotinoids for preparing medicaments for treating dermatoses |
11/19/1997 | EP0679157B1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
11/19/1997 | CN1165011A Enternal use adhesive plaster for treatment of rheumatism |
11/18/1997 | US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
11/18/1997 | US5688949 Pyrazolo 1,5-A!pyrimidine derivatives and anti-inflammatory agent containing the same |
11/18/1997 | US5688922 Chemical intermediates for glycyrrhetinic acid derivatives, selectin ligands, inhibitors of leukotriene biosynthesis |
11/18/1997 | US5688825 Sulfonyloxysuccimides |
11/18/1997 | US5688820 Nervous system disorders; psychological disorders |
11/18/1997 | US5688817 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
11/18/1997 | US5688811 Psychological disorders; nervous system disorders |
11/18/1997 | US5688806 Antiinflammatory agents and central nervous system disorders |
11/18/1997 | US5688805 Inhibitors of tumor necrosis factor-a, treatment of septic shock, antiinflammatory, antiallergen |
11/18/1997 | US5688804 3-Benzylamino-2-phenyl-piperidine derivatives as substance P receptor antagonists |
11/18/1997 | US5688788 N-substituted azaheterocyclic carboxylic acids and esters thereof |
11/18/1997 | US5688529 Immunosuppresants, antiinflammatory, antitumor, antiproliferative, antiviral, antipsoriatic agents |
11/13/1997 | WO1997042337A1 Gene expression in monocytes and macrophages |
11/13/1997 | WO1997042214A1 Androstene derivatives |
11/13/1997 | WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
11/13/1997 | WO1997041882A1 Method for treating inflammation |
11/13/1997 | WO1997041862A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
11/13/1997 | WO1997041831A1 Stimulation of immune response with low doses of il-2 |
11/13/1997 | WO1997041824A2 Antiangiogenic peptides derived from plasminogen |
11/13/1997 | WO1997033996A3 Human bikunin |
11/13/1997 | WO1997032607A3 Activated linkers and methods for making and purifying the same |
11/13/1997 | WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
11/13/1997 | DE19619036A1 Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with carbo- or heterocyclic substituent at C-25, process for their preparation and the use thereof for producing medicaments |
11/13/1997 | CA2253322A1 Gene expression in monocytes and macrophages |
11/13/1997 | CA2253312A1 Method for treating inflammation |
11/13/1997 | CA2205121A1 Antiadhesive properties of polyacrylic acids and polymethacrylic acids |
11/12/1997 | EP0806423A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
11/12/1997 | EP0805796A1 Cell adhesion inhibitors |
11/12/1997 | EP0805675A1 Directly compressible high load acetaminophen formulations |
11/12/1997 | EP0659080A4 Method and composition for the treatment of hair loss. |
11/12/1997 | CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them |
11/12/1997 | CN1036393C 7-(2-aminoethyl)-benzothiazolones |
11/11/1997 | US5686628 Proline derivatives |
11/11/1997 | US5686615 Stereoselective preparation of substituted piperidines |
11/11/1997 | US5686609 Aromatic amine compounds, Their method of preparation and pharmaceutical compositions in which they are present |
11/11/1997 | US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes |
11/11/1997 | US5686485 Physiologically active EI-1941 compounds |
11/11/1997 | US5686478 Endothelin antagonists |
11/11/1997 | US5686471 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
11/11/1997 | US5686463 Oxadiazoles useful in the treatment of senile dementia |
11/11/1997 | US5686462 Anti-inflammatory method |
11/11/1997 | US5686460 Antiinflammatory agents, analgesics |
11/11/1997 | US5686459 Anticoagulants |
11/11/1997 | US5686455 Imidazole derivatives and their use as cytokine inhibitors |
11/11/1997 | US5686434 3-aryl-2-isoxazolines as antiinflammatory agents |
11/11/1997 | US5686431 Methods of using low molecular weight heparins for treatment of pathological processes |
11/11/1997 | US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
11/11/1997 | US5686424 For treating inflammation |
11/11/1997 | US5686070 Methods for treating bacterial pneumonia |
11/06/1997 | WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
11/06/1997 | WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
11/06/1997 | WO1997041127A1 Halo-substituted protein kinase c inhibitors |
11/06/1997 | WO1997041104A1 Quinoline derivatives, processes for their preparation, and their use as medicaments |
11/06/1997 | WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis |
11/06/1997 | WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis |
11/06/1997 | WO1997041096A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
11/06/1997 | WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
11/06/1997 | WO1997040836A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
11/06/1997 | WO1997040830A1 Therapeutic treatment for vegf related diseases |
11/06/1997 | WO1997035969A3 Peptide ligands of the urokinase receptor |
11/06/1997 | CA2253608A1 Therapeutic treatment for vegf related diseases |
11/06/1997 | CA2253288A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
11/06/1997 | CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
11/06/1997 | CA2252876A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
11/06/1997 | CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
11/06/1997 | CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis |
11/05/1997 | EP0805158A2 Halo-substituted protein kinase C inhibitors |
11/05/1997 | EP0804479A1 Method of treating diabetes mellitus using kgf |
11/05/1997 | EP0804471A1 Gnrh antagonists |
11/05/1997 | EP0804469A1 Novel peptide |
11/05/1997 | EP0804468A1 Conformationally constrained backbone cyclized peptide analog |
11/05/1997 | EP0804465A1 Novel elastase inhibitors |
11/05/1997 | EP0804463A1 Neurokinine (tachykinine) antagonists |
11/05/1997 | EP0804459A1 Therapeutic compound - fatty acid conjugates |
11/05/1997 | EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF |
11/05/1997 | EP0804430A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids |
11/05/1997 | EP0804427A1 Lta4 hydrolase inhibitors |
11/05/1997 | EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists |
11/05/1997 | EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
11/05/1997 | EP0804228A1 The use of activated protein c for preparing a pharmaceutical preparation |
11/05/1997 | EP0804225A1 Pharmaceutical compositions comprising a superoxide dismutase |
11/05/1997 | EP0804218A1 Product and process for regulating signal transduction pathways |
11/05/1997 | EP0804211A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
11/05/1997 | EP0804207A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds |
11/05/1997 | EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition |
11/05/1997 | EP0804181A1 Method and composition for treating mammalian diseases caused by inflammatory response |
11/05/1997 | EP0662957B1 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
11/05/1997 | EP0636119B1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
11/05/1997 | CN1164234A Pyrrolo £2,3-d| pyrimidines and their use |
11/05/1997 | CN1163895A Novel prodrugs for therapy of tumors and inflammatory disorders |
11/05/1997 | CN1163884A Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
11/04/1997 | US5684205 Use of substituted cyclopentane- di- and -triones |